ClinicalThought

Share

Program Content

Activities

  • Molecular Features in GynOnc
    Molecular Features in Gynecologic Cancers and the Optimal Use of PARP Inhibitors
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 14, 2022

    Expires: July 13, 2023

Provided by

ProCE Banner

Supporters

AstraZeneca

Eisai Inc.

GlaxoSmithKline

ImmunoGen, Inc.

Merck Sharp & Dohme Corp.